At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 54 enrolled
Drug / intervention
Transcranial Direct Current Stimulation (tDCS) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Transcranial Direct Current Stimulation Paired With Robotic Arm Therapy on Recovery of Upper Extremity Motor Function in Stroke Patients
In Brief
A Phase 2 clinical trial evaluating Transcranial Direct Current Stimulation (tDCS) and Placebo sham for Stroke. Completed, enrolled 54 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate if multiple therapy sessions of Transcranial Direct Current Stimulation (tDCS non-invasive brain stimulation) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy alone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2012
First PostedNov 2012
Primary CompletionJan 2018
Study CompletionJun 2018
TodayJul 2026
First PostedNov 15, 2012
Enrollment StartSep 1, 2012
Primary CompletionJan 1, 2018
Study CompletionJun 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 13.6 years ago
Interventions
Transcranial Direct Current Stimulation (tDCS)device
Placebo shamdevice